Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva Pharmaceutical Industries has launched nicardipine hydrochloride injection, 2.5mg/ml which is AP-rated to EKR Therapeutics's hypertension treatment Cardene IV.
Subscribe to our email newsletter
Teva is manufacturing and distributing the product, under license, as part of a license and distribution agreement entered into between Teva and Exela PharmSci, a Reston, Virginia pharmaceutical development company.